BEIJING -- Chinese internet conglomerate Alibaba Group Holding has submitted a paper that claims it has successfully developed cardiovascular recognition technology, which if proven true, will have wide-ranging impact on the diagnosis and treatment of heart disease.
The group's science and innovative technology research institute, Machine Intelligence laboratory of Alibaba DAMO Academy, submitted the paper to the International Conference on Medical Image Computing and Computer Assisted Intervention ahead of the 22nd convention in autumn.
